21,739,131 Shares of Common Stock Warrants to Purchase up to 21,739,131 Shares of Common Stock AVEO PHARMACEUTICALS, INC. PURCHASE AGREEMENTPurchase Agreement • April 4th, 2019 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • New York
AVEO Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to sell to H.C. Wainwright & Co., LLC, as underwriter (the “Underwriter”) an aggregate of (i) 21,739,131 authorized but unissued shares (the “Firm Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company and (ii) Warrants (as defined below) (the “Firm Warrants”) to purchase up to an aggregate of 21,739,131 shares of Common Stock (the “Firm Warrant Shares”). As used herein, a “Warrant” refers to a warrant to purchase one share of Common Stock, substantially in the form attached hereto as Exhibit A. The Firm Shares and the Firm Warrants are referred to herein as the “Firm Securities.”
